The Body Covers:
The 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
Athenaeum Inter-Continental, Athens, Greece
October 23-26, 2001
The International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV is an opportunity for leading clinicians and scientists to discuss abnormalities and side effects associated mainly with highly active antiretroviral therapy (HAART). The conference is organized by the International Medical Press, whose goal is to promote exchanges of information and opinion between members of the scientific and medical communities.
In light of the prevalence of metabolic abnormalities among HIV-positive individuals treated with HAART, this year's conference will seek to help professionals better understand these adverse effects. Scientists and clinicians will also share the latest available therapy information. For more on this conference, visit: conferences.intmedpress.com/lipodystrophy.
Reporting exclusively for The Body at this workshop is Dr. Graeme Moyle.
Funding for The Body's conference coverage is provided, in part, by unrestricted educational grants from Boehringer-Ingelheim, Bristol-Myers Squibb and GlaxoSmithKline.
Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.